Resmed Inc
RMDToday
-0.37%
5 Days
-4.98%
1 Month
+2.58%
6 Months
-9.17%
Year to Date
-4.42%
1 Year
-16.71%
Recent
Analysis
Resmed Inc Stock (RMD) Moved Down by 3.25% on Sep 1: Facts Behind the Movement
• ResMed faces volatility from Astral ventilator sales suspensions and strategic portfolio adjustments. • Management reports under-penetrated sleep apnea markets despite ongoing debate over GLP-1 therapies. • The company generated $5.65B in annual revenue with net profit reaching $1.52B.
Resmed Inc Stock (RMD) Moved Up by 3.43% on Aug 19: What Investors Need To Know
• ResMed gained momentum from capital allocation milestones and increased quarterly dividends. • Divesting MatrixCare and strong core sleep device demand support constructive sentiment. • Technical indicators like MACD and Williams %R suggest buy signals.
Resmed Inc Stock (RMD) Moved Up by 3.01% on Aug 10: Key Drivers Unveiled
• ResMed reported strong recurring revenue from its AirSense platform and software ecosystem. • Clinical insights suggest GLP-1 drugs increase sleep apnea diagnosis rates and patient engagement. • ResMed solidified market share as its primary competitor faces ongoing regulatory constraints.
Resmed Inc Stock (RMD) Closed Down by 5.22% on Aug 7: What Investors Need To Know
• ResMed gross margins contracted due to product mix shifts and elevated logistical expenses. • Concerns over GLP-1 weight-loss drugs create long-term uncertainty for CPAP market growth. • Increased competition and higher operating expenses are pressuring short-term profitability and investor sentiment.
Resmed Inc's Score
Media Coverage
Analyst Rating
Resmed Inc Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Resmed Inc Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.53% |
| BlackRock Institutional Trust Company, N.A. | 6.03% |
| Vanguard Portfolio Management, LLC | 5.42% |
| State Street Investment Management (US) | 4.57% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 39.48% |
| Investment Advisor/Hedge Fund | 20.55% |
| Research Firm | 2.80% |
| Pension Fund | 2.77% |
Related Instruments
Popular Instruments
